Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | FHI | CGAU |
|---|---|---|
| Price | $56.50 | $21.56 |
| Change today | ▲ 0.77% | ▲ 0.61% |
| Market cap | $4.22B | $4.22B |
| Return, 3 months | – | +33.5% |
| Return, year to date | – | +51.3% |
| Return, 1 year | – | +87.2% |
| P/E (TTM) | 10.5 | 6.9 |
| P/B | 3.4 | 1.9 |
| P/E percentile vs own 5y | – | 61st |
| Dividend yield | 2.48% | 0.94% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +5.6% | +9.4% |
| Analyst buy share | 33% | 60% |
| RSI (14) | – | 45 |
| 30-day volatility | – | 37.2% |
| Max drawdown, 1 year | – | -29.5% |
| Trend read | – | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
